SXTC · China SXT Pharmaceuticals Inc
United States · RS rating 1 · As of 2026-11-03
| Price | 2.88 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 1 / 1 / 1 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 2 / 15 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +100.0% |
| Market cap (USD) | $2.0M |